Practical Applications of New Agents in Oncology

7:20 – 10:05 a.m.

Registration and Breakfast

7:20 – 8:00 a.m.

Opening remarks: MCC/UTHSCSA

8:00 – 8:10 a.m.

Session 1. New Drugs in Oncology (1) 

8:10 – 8:50 a.m. 

Overview of Novel Drug Development in Oncology 

8:50 – 9:20 a.m.

Drug development in protein kinase inhibitor (Pancreatic Ca and KRAS inhibitors) 

9:20 – 9:50 a.m.

Drug development in antibody-drug conjugate

9:50 – 10:05 a.m. 

Questions/Answers

10:05 – 10:20 a.m.

Break and exhibition

10:20 a.m. – 

12:15 p.m.

Session 2. New Drugs in Oncology (2) 

10:20 – 11:00 a.m.

Drug development in Tumor Microenvironment Regulation

11:00 – 11:30 a.m.

Drug development in cell cycle checkpoint inhibition

11:30 a.m.  – 12:00 p.m.

Breast Cancer Immunotherapy

12:00 – 12:15 p.m. 

Questions/Answers

1:35 – 4:35 p.m.

Session 3. New Drugs in Hematology

1:35 – 2:15 p.m.

Overview of New Drugs in Hematology 

2:15 – 2:45 p.m. 

Drug development in Epigenetic regulation

2:45 – 3:15 p.m. 

Drug development if DNA repair and synthetic lethality

3:15 – 3:45 p.m.

Drug development in immune checkpoint and cytosine modulation, CAR T-cell therapy, Drug development in vaccine

3:45 – 4:15 p.m.

Gene therapy

4:15 – 4:30 p.m. 

Questions/Answers

4:30 p.m.

Adjourn

8:00 – 9:45 a.m.

Breakfast, BioPharma Lecture, and Exhibit, Moderator: 

8:15 – 8:45 a.m.

Business development for new drugs 

8:45 – 8:50 a.m.

Questions/Answers

8:50 – 9:20 a.m.

Break and Exhibit

9:20 AM – 12:00 p.m.

Session 4. Drug Development and Translational Research

9:20 – 9:50 a.m.

Role of genetics in new drug discovery 

9:50 - 10:20 a.m.

HR and NHEJ repair in cancer drug development 

10:20 AM – 10:50 a.m.

Translational research (Investigator initiated Trials)

10:50 AM – 11:00 a.m.

Questions/Answers

12:00 – 1:00 p.m.

Lunch break, networking, and exhibition

1:00 – 2:15 p.m.

Session 5. Case Studies in Molecular Targeted Treatment of Cancer 

1:00 – 1:15 p.m.

1:15 – 1:30 p.m.

1:30 – 1:45 p.m.

1:45 – 2:00 p.m.

Bioinformatics in Cancer Treatment

Case 1

Case 2

Summary

2:00 – 2:15 p.m.

Questions/Answers

2:15 – 4:10 p.m.

Session 6. Clinical trials and Abstract Award Presentations

2:15 – 2:45 p.m.

Pharmacy: Role of pharmacists in phase 1 trial

2:45 – 3:15 p.m.

Nursing

3:15 – 3:30 p.m.

Questions/Answers

3:30 – 4:05 p.m.

Closing remarks